AD patients showed higher peripheral IL-23 levels (Chen et al. 2014a, b) and the p40 subunit concentration was considered a serum biomarker through which the Aβ load could be predicted in AD (Pedrini et al. 2017). Here, IL9 is linked to Alzheimer disease.